Home 2022
Yearly Archives: 2022
News
Dupixent approved in U.S. for adolescents with chronic rhinosinusitis with nasal polyps
The U.S. Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals and Sanofi's Dupixent (dupilumab) as an add-on maintenance treatment for adolescent patients aged...
FDA approves OCREVUS ZUNOVO as the first and only twice-a-year 10-minute subcutaneous injection for...
The United States Food and Drug Administration (U.S. FDA) has approved Roche's OCREVUS ZUNOVO (ocrelizumab & hyaluronidase-ocsq) for the treatment of relapsing multiple sclerosis...
Pioneer Group and Novo Nordisk team up on Golden Ticket Programme for cardiometabolic health...
Pioneer Group, a specialist in life science infrastructure and venture building, has teamed up with global healthcare company Novo Nordisk to launch a Golden...
